Profile Pharma Limited

Chichester Business Park, City Fields Way, Tangmere, Chichester, West Sussex, PO20 2FT
Telephone: +44 (0)800 1300 855
Fax: +44 (0)800 1300 856
WWW: http://www.profilepharma.com
Medical Information Direct Line: +44 (0)870 423 1475
Medical Information e-mail: info@profilepharma.com
Out of Hours contact: +44 (0)700 593 8988

Patient Information Leaflet last updated on the eMC: 12/04/2011
PIL Promixin 1 million International Units (IU) Powder for Nebuliser Solution

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 12/04/2011 and displayed until Current
Reasons for adding or updating:
  • Change to appearance of the medicine
  • Change to date of revision
  • Change of contra-indications
Updated on 19/03/2009 and displayed until 12/04/2011
Reasons for adding or updating:
  • Change of manufacturer
  • Change to instructions about overdose
Updated on 04/12/2008 and displayed until 19/03/2009
Reasons for adding or updating:
  • Change to date of revision
  • Correction of spelling/typing errors
Updated on 05/02/2008 and displayed until 04/12/2008
Reasons for adding or updating:
  • Change of manufacturer
  • Change to date of revision
  • Change due to user-testing of patient information
Updated on 06/03/2007 and displayed until 05/02/2008
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 22/01/2007 and displayed until 06/03/2007
Reasons for adding or updating:
  • Change to MA holder contact details
  • Change to date of revision
Updated on 20/03/2006 and displayed until 22/01/2007
Reasons for adding or updating:
  • Change to information about the device
  • Change to date of revision
Updated on 28/09/2004 and displayed until 20/03/2006
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to storage instructions
  • Change to side-effects
  • Change to date of revision
  • Change to how to administer the medicine
Updated on 20/01/2004 and displayed until 28/09/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 09/12/2003 and displayed until 20/01/2004
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   colistimethate sodium